NNC0519-0130
A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.
Novo Nordisk · Phase 1 · Completed · Enrollment 161
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Single ascending dose (SAD) part | n/r | n/r | n/r | n/r | n/r |
| Multiple ascending dose (MAD) QD part | n/r | n/r | n/r | n/r | n/r |
| Type 2 diabetes (T2D) part | n/r | n/r | n/r | n/r | n/r |
| MAD QW part | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.